Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02853019
What this trial is testing

Emotion and Motivation in Patients With Psychosis

Who this might be right for
Schizophrenia
University Hospital, Strasbourg, France 41
Post-approval studies (Phase 4)UnknownNCT00480844
What this trial is testing

Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone

Who this might be right for
Schizophrenia
Sheba Medical Center 60
Not applicableUnknownNCT01167348
What this trial is testing

The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia

Who this might be right for
SchizophreniaObesity
TsaoTun Psychiatric Center, Department of Health, Taiwan 86
Not applicableStudy completedNCT04298450
What this trial is testing

ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention

Who this might be right for
First Episode PsychosisPsychosisPsychotic Episode+8 more
Centre for Addiction and Mental Health 186
Large-scale testing (Phase 3)Study completedNCT00085891
What this trial is testing

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 535
Not applicableEnded earlyNCT01324297
What this trial is testing

The Topical Niacin Skin Flush Test in First Episode Psychosis

Who this might be right for
Psychotic DisordersSchizophrenia
Nova Scotia Health Authority 107
Not applicableStudy completedNCT01959659
What this trial is testing

A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness

Who this might be right for
Schizophrenia
Hoffmann-La Roche 1,431
Large-scale testing (Phase 3)UnknownNCT04093518
What this trial is testing

Estradiol as add-on to Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Tangent Data 100
Not applicableLooking for participantsNCT05704582
What this trial is testing

RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders

Who this might be right for
Psychotic DisordersCannabis Use DisorderMental Health Disorder
Ciusss de L'Est de l'Île de Montréal 150
Post-approval studies (Phase 4)Study completedNCT00485823
What this trial is testing

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Who this might be right for
Schizophrenic Disorders
Eli Lilly and Company 48
Not applicableStudy completedNCT02748486
What this trial is testing

Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...

Who this might be right for
SchizophreniaPsychotic Disorders
University of Warsaw 38
Testing effectiveness (Phase 2)Study completedNCT00257023
What this trial is testing

An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 52
Post-approval studies (Phase 4)Study completedNCT01947803
What this trial is testing

A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 353
Large-scale testing (Phase 3)Study completedNCT04659174
What this trial is testing

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Who this might be right for
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 152
Not applicableStudy completedNCT00980252
What this trial is testing

Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention

Who this might be right for
SchizophreniaPsychotic Disorders
University of Illinois at Chicago 34
Large-scale testing (Phase 3)Study completedNCT02469155
What this trial is testing

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 696
Not applicableEnded earlyNCT05526833
What this trial is testing

An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study

Who this might be right for
Schizophrenia and Related Disorders
Columbia University 3
Not applicableStudy completedNCT03548155
What this trial is testing

Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

Who this might be right for
SchizophreniaTherapeutics
Tianjin Anding Hospital 65
Not applicableStudy completedNCT03590015
What this trial is testing

Recruitment of Patients Through Invitation Letters

Who this might be right for
Recruitment, Invitation Letters, Patients With Schizophrenia
Aalborg University Hospital 84
Not applicableStudy completedNCT04442893
What this trial is testing

Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy in Patients With Schizophrenia

Who this might be right for
Randomized Controlled Trial
National Yang Ming Chiao Tung University 85
Next Page